SARS-CoV-2 vaccine response and rate of breakthrough infection in patients with hematological disorders
J Hematol Oncol. 2022 May 7;15(1):54. doi: 10.1186/s13045-022-01275-7.ABSTRACTBACKGROUND:…
Unsupervised machine learning improves risk stratification in newly diagnosed multiple myeloma: an analysis of the Spanish Myeloma Group
Blood Cancer J. 2022 Apr 25;12(4):76. doi: 10.1038/s41408-022-00647-z.ABSTRACTThe…
A simple score to predict early severe infections in patients with newly diagnosed multiple myeloma
Blood Cancer J. 2022 Apr 19;12(4):68. doi: 10.1038/s41408-022-00652-2.ABSTRACTInfections…
COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry
J Natl Cancer Inst. 2022 Jul 11;114(7):979-987. doi: 10.1093/jnci/djac057.ABSTRACTBACKGROUND:…
The outcome of patients with Hodgkin lymphoma and early relapse after autologous stem cell transplant has improved in recent years
Leukemia. 2022 Jun;36(6):1646-1653. doi: 10.1038/s41375-022-01563-8.…
Worldwide Network for Blood and Marrow Transplantation Special Article on Key Elements in Quality and Accreditation in Hematopoietic Stem Cell Transplantation and Cellular Therapy
Transplant Cell Ther. 2022 Aug;28(8):455-462. doi: 10.1016/j.jtct.2022.04.003.…
Impact of the SARS-CoV-2 pandemic on hematopoietic cell transplantation and cellular therapies in Europe 2020: a report from the EBMT activity survey
Bone Marrow Transplant. 2022 May;57(5):742-752. doi: 10.1038/s41409-022-01604-x.…
Cost-Effectiveness Analysis of Axicabtagene Ciloleucel vs. Tisagenlecleucel for the Management of Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Spain
Cancers (Basel). 2022 Jan 21;14(3):538. doi: 10.3390/cancers14030538.ABSTRACTThe…
Mass spectrometry vs immunofixation for treatment monitoring in multiple myeloma
Blood Adv. 2022 Jun 14;6(11):3234-3239. doi: 10.1182/bloodadvances.2021006762.ABSTRACTMonitoring…
Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia
N Engl J Med. 2022 Jan 6;386(1):11-23. doi: 10.1056/NEJMoa2109965.ABSTRACTBACKGROUND:…
Hodgkin Lymphoma: Recent Progress in Overall Management
In: Gallamini A, Juweid M, editors. Lymphoma [Internet]. Brisbane…
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma
N Engl J Med. 2022 Feb 17;386(7):629-639. doi: 10.1056/NEJMoa2116596.…
